Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Low Dose Naltrexone (LDN) (naltrexone) Treatment Report
What is Low Dose Naltrexone (LDN)?

Naltrexone, in low doses such as 3mg to 4.5mg, has been found to boost the immune system in MS, autoimmune diseases, and central nervous system disorders. Naltrexone was FDA-approved in 1985 for the management of alcohol dependence and opioid dependence at 50mg doses. Read more...Click to read more below

Side Effects

Side effects as an overall problem

Severe
1 1%
Moderate
4 6%
Mild
12 17%
None
54 76%

Most commonly reported side effects

Vivid dreams
9 13%
Morning stiffness
5 7%
Leg spasms (both)
4 6%
early morning wakefullness
3 4%
Insomnia
2 3%
Bowel urgency
1 1%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Low Dose Naltrexone (LDN). See all 21 dosages

  3.5 mg all the time (24/7) daily 0.4 mg daily 1 daily 1 mg daily 1.5 mcg daily 1.5 mg daily 1.5 mL daily 1.75 mg daily 2 mg daily 2 mL daily 4.5 mg 2.5 mg daily 3 mg daily 3.5 mg daily 4 mg daily 4.25 mg daily 4.5 mg daily 5 mg daily 6 mg daily 9 mg daily
  1 Number of Patients: 1 6 Number of Patients: 6 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 11 Number of Patients: 11 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 65 Number of Patients: 65 10 Number of Patients: 10 9 Number of Patients: 9 1 Number of Patients: 1 141 Number of Patients: 141 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Low Dose Naltrexone (LDN) (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
21 46% Did not seem to work: 46%
Other
11 24% Other: 24%
Side effects too severe
10 22% Side effects too severe: 22%
Doctor's advice
8 17% Doctor's advice: 17%
Personal research
3 7% Personal research: 7%
Expense
3 7% Expense: 7%
Course of treatment ended
2 4% Course of treatment ended: 4%
Not indicated
1 2% Not indicated: 2%

See all 46 patients who’ve stopped taking Low Dose Naltrexone (LDN)

Currently Taking Low Dose Naltrexone (LDN)

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
4
13
29
35
30
40

Stopped Taking Low Dose Naltrexone (LDN)

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
9
9
9
8
7

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
66 93%
Usually
5 7%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
2 3%
Somewhat
0 0%
A little
6 8%
Not at all
63 89%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
10 14%
$25-49
36 51%
< $25
24 34%

Report created on November 23, 2009.